Ovid Therapeutics Inc (OVID)
1.18
+0.06
(+5.36%)
USD |
NASDAQ |
Sep 27, 16:00
1.175
0.00 (0.00%)
After-Hours: 20:00
Ovid Therapeutics Cash from Operations (Quarterly): -14.26M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -14.26M |
| March 31, 2024 | -16.69M |
| December 31, 2023 | -11.91M |
| September 30, 2023 | -10.05M |
| June 30, 2023 | -11.71M |
| March 31, 2023 | -12.11M |
| December 31, 2022 | -9.176M |
| September 30, 2022 | -12.68M |
| June 30, 2022 | -13.29M |
| March 31, 2022 | -20.09M |
| December 31, 2021 | -12.00M |
| September 30, 2021 | -10.87M |
| June 30, 2021 | -19.42M |
| March 31, 2021 | 160.90M |
| December 31, 2020 | -14.51M |
| September 30, 2020 | -1.469M |
| June 30, 2020 | -17.19M |
| Date | Value |
|---|---|
| March 31, 2020 | -18.41M |
| December 31, 2019 | -16.89M |
| September 30, 2019 | -9.494M |
| June 30, 2019 | -11.84M |
| March 31, 2019 | -12.87M |
| December 31, 2018 | -10.97M |
| September 30, 2018 | -10.05M |
| June 30, 2018 | -11.62M |
| March 31, 2018 | -12.93M |
| December 31, 2017 | -9.006M |
| September 30, 2017 | -9.322M |
| June 30, 2017 | -5.986M |
| March 31, 2017 | -7.156M |
| December 31, 2016 | -5.712M |
| September 30, 2016 | -4.636M |
| June 30, 2016 | -3.609M |
| March 31, 2016 | -3.845M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-20.09M
Minimum
Mar 2022
160.90M
Maximum
Mar 2021
-4.565M
Average
-12.39M
Median
Cash from Operations (Quarterly) Benchmarks
| Eli Lilly and Co | 1.466B |
| Tonix Pharmaceuticals Holding Corp | -9.919M |
| GlycoMimetics Inc | -8.893M |
| NovaBay Pharmaceuticals Inc | -0.578M |
| Palatin Technologies Inc | -8.607M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 12.82M |
| Cash from Financing (Quarterly) | 0.356M |
| Free Cash Flow | -53.08M |
| Free Cash Flow Per Share (Quarterly) | -0.2023 |
| Free Cash Flow to Equity (Quarterly) | -14.40M |
| Free Cash Flow to Firm (Quarterly) | -14.40M |
| Free Cash Flow Yield | -63.53% |